• |
  • |
  • |
  • |
Donate

Project

Study to Investigate Long-Term Safety and Efficacy of GS-100

Center:
Fiscal Year:
2024
Contact Information:
Project Description:
A Phase 1/2/3 Open-Label, Single Arm, Dose-Finding Study to Investigate Long-Term Safety and Efficacy of GS-100, an Adeno-Associated Virus Serotype 9(AA V9) Vector-Mediated Gene Transfer of Human NGLY, in Patients with NGLY1 Deficiency Grace Science Foundation Industry Funded Co-Investigator, Suter (PI) 01/2024 – present
Keyword(s):
Core Function(s):
Performing Direct and/or Demonstration Services, Performing Research or Evaluation, Continuing Education/Community Training
Area of Emphasis
Other
Target Audience:
Adults with Disabilities, Children/Adolescents with Disabilities/SHCN
Unserved or Under-served Populations:
Other
Primary Target Audience Geographic Descriptor:
National
Funding Source:
COVID-19 Related Data:
N/A